Ngenra subcutaneous injection 60mg pen, manufactured by Pfizer, contains Somatropin (genetically recombined). This injectable drug is used to treat growth disorders caused by growth hormone deficiency. It is supplied as 60 mg/1.2 mL/kit, with YJ code 2412404G2020.
Ngenra subcutaneous injection 60mg pen
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →